insights_auto
Outlook: 17.4% bullish·8.7% bearish
Go to analysischevron_right
ABBV:NYSE
AbbVie Common Stock
$286.20
arrow_upward
+0.94%(+2.66) 1D
$286.20
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:02:46 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
$286.83
High
$290.23
Low
$284.85
Mkt. cap
505.89B
Avg. vol.
5.26M
Volume
8.77M
Dividend
2.54%
Quarterly dividend
$1.82
Ex-dividend date
Oct 15, 2026
P/E ratio
49.27
52-wk high
$301.20
52-wk low
$190.75
EPS
$5.81
Beta
0.21
Shares outstanding
1.77B
No. of employees
57K
Open
$286.83
High
$290.23
Low
$284.85
Mkt. cap
505.89B
Avg. vol.
5.26M
Volume
8.77M
Dividend
2.54%
Quarterly dividend
$1.82
Ex-dividend date
Oct 15, 2026
P/E ratio
49.27
52-wk high
$301.20
52-wk low
$190.75
EPS
$5.81
Beta
0.21
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
24/7 Wall St.
·
1 day ago
$500,000 in AbbVie and Gilead Could Pay More Than $11,000 a Year in Dividends
The Motley Fool
·
1 day ago
AbbVie (ABBV) Stock Just Got a 5.2% Dividend Increase. Here's How Many Shares You Need to Generate $1,000 a Year.
Yahoo Finance
·
1 day ago
Is Solid Tumor Partnership Altering The Investment Case For AbbVie (ABBV)?
The Motley Fool
·
2 days ago
AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com